4.3 Review

Possible Role of Toll-Like Receptor 4 in Acute Pancreatitis

期刊

PANCREAS
卷 39, 期 6, 页码 819-824

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MPA.0b013e3181ca065c

关键词

acute pancreatitis; toll-like receptor 4

资金

  1. Technological Foundation Project of Traditional Chinese Medicine Science of Zhejiang province [2003C130, 2004C142]
  2. Foundation Project for Medical Science and Technology of Zhejiang province [2003B134]
  3. Grave Foundation Project for Technological and Development of Hangzhou [2003123B19]
  4. Intensive Foundation Project for Technology of Hangzhou [2004Z006]
  5. Foundation Project for Medical Science and Technology of Hangzhou [2003A004]
  6. Foundation Project for Technology of Hangzhou [2005224]

向作者/读者索取更多资源

Because the mechanism underlying the development of acute pancreatitis (AP) has not yet been fully clarified, it has been a hot but difficult topic in basic and clinical research for a long time. Currently, the dominant hypothesis for the pathogenesis of AP is that it is a disease of self-digestive acute chemical inflammation induced by trypsin activation. As proteins to trigger the inflammatory response cascade, Toll-like receptors (TLRs), especially TLR4, provide a new clue for studying the pathogenesis of AP from the source. Some studies have found that when TLR4 is activated by certain factors, it can amplify an inflammatory effect and aggravate the body's inflammatory response through a series of signal transduction. Toll-like receptor 4 may play an important role in the synthesis and release of proinflammatory cytokines, and the up-regulation of the TLR4 gene may be related with the development and progression of multiple organ injury during AP. As the gate'' of inflammatory response, TLR4 may be closely associated with the development and progression of multiple organ injury during AP. Understanding the roles of TLR4 in AP will help to further clarify the pathogenesis of AP and to search a new target for the treatment of AP.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Diagnosing MonoMAC Syndrome in GATA2 Germline Mutated Myelodysplastic Syndrome via Next-Generation Sequencing in a Patient with Refractory and Complex Infection: Case Report and Literature Review

Yingying Shen, Yuzhu Li, Hangchao Li, Qi Liu, Huijie Dong, Bo Wang, Baodong Ye, Shenyun Lin, Yiping Shen, Dijiong Wu

Summary: MonoMAC syndrome is a rare disease that should be highly suspected in MDS/AML patients with recurrent mixed infections and pancytopenia, especially with monocyte absence. Genetic mutation and pathogen sequencing are important for diagnosis and treatment.

INFECTION AND DRUG RESISTANCE (2021)

Article Immunology

Efficiency and safety of eltrombopag for multi-line failed Chinese patients with immune thrombocytopenia: cases with decreased megakaryocyte response well from single-center experience

Qi Liu, Yingying Shen, Yuzhu Li, Huijin Hu, Wenbin Liu, Yuechao Zhao, Huijie Dong, Yiping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Summary: The study demonstrated that ITP patients with decreased megakaryocyte responded well to eltrombopag, and abnormalities in NK cells may contribute to a poor response to eltrombopag.

IMMUNOLOGIC RESEARCH (2022)

Article Cell Biology

Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors

Yanting Gao, Qi Liu, Yingying Shen, Yuzhu Li, Keding Shao, Baodong Ye, Yiping Shen, Yuhong Zhou, Dijiong Wu

Summary: This study reported a single-center study of avatrombopag, a novel drug for the treatment of severe and refractory chemotherapy-induced thrombocytopenia (CIT). The results demonstrated that avatrombopag was effective in 8 out of 13 patients (61.5%), with most patients no longer requiring platelet transfusion at the end of the study. Hemoglobin level and platelet count could serve as predictors of treatment response. This study provides a new and effective treatment option for CIT.

PLATELETS (2022)

Article Integrative & Complementary Medicine

Bushen Jianpi Quyu Formula Alleviates Myelosuppression of an Immune-Mediated Aplastic Anemia Mouse Model via Inhibiting Expression of the PI3K/AKT/NF-κB Signaling Pathway

Hangchao Li, Lina Ji, Yingying Shen, Danqing Fu, Dijiong Wu, Baodong Ye

Summary: This study demonstrated the therapeutic effects of BSJPQYF in aplastic anemia, which could alleviate myelosuppression through inhibiting the expression of the PI3K/AKT/NF-kappa B signaling pathway.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2022)

Article Integrative & Complementary Medicine

Medication Regularity of Traditional Chinese Medicine in the Treatment of Aplastic Anemia Based on Data Mining

Nanxi Dong, Xujie Zhang, Dijiong Wu, Zhiping Hu, Wenbin Liu, Shu Deng, Baodong Ye

Summary: This study explores the medication rules for aplastic anemia (AA) in traditional Chinese medicine (TCM) using data mining methods. The results reveal commonly used herbs, their properties, and the clustering of medications. Association rule analysis identifies the relationships between high-frequency herbs.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2022)

Article Biochemistry & Molecular Biology

Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study

Qi Liu, Huijie Dong, Yuzhu Li, Yingying Shen, Yilei Hong, Ying Chen, Shan Liu, Xiaolian Wu, Wenbin Liu, Huijin Hu, Yuechao Zhao, Shenyun Lin, Yiping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Summary: This study aimed to explore the relationship between serum lipid changes and responses to ATG-based IST treatment for newly diagnosed SAA/VSAA patients. The results demonstrated that lower levels of Apo-A were associated with better event-free survival.

LIPIDS IN HEALTH AND DISEASE (2022)

Article Hematology

Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study

Yingying Shen, Qi Liu, Hangchao Li, Wenbin Liu, Huijin Hu, Yuechao Zhao, Yuzhu Li, Ying Chen, Shan Liu, Qinghong Yu, Haifeng Zhuang, Liqiang Wu, Zhiping Hu, Zhiyin Zheng, Jianping Shen, Shenyun Lin, Yiping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Summary: Acquired aplastic anemia (AA) is a bone marrow failure disorder characterized by low blood cell count, and immunosuppressive therapy (IST) is a common treatment option. This study found a high prevalence of FANC heterozygous germline mutations in AA patients, which were associated with poor response to IST.

ANNALS OF HEMATOLOGY (2023)

Meeting Abstract Hematology

Apolipoprotein-a Is a Potential Prognosis Biomarker for Severe Aplastic Anemia Patients Treated with ATG-Based Immunosuppressive Therapy: A Single-Center Retrospective Study

Qi Liu, Huijie Dong, Yingying Shen, Yuzhu Li, Yilei Hong, Ying Chen, Shan Liu, Wenbin Liu, Huijin Hu, Yuechao Zhao, Shengyun Lin, Yiping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Meeting Abstract Hematology

Synergistic Effect of Low-Dose Cyclosporine a on Eltrombopag (EPAG) in the Management of Prior Epag and Multiline Failed Immune Thrombocytopenia Patients: A Single-Center, Self-Control Study

Yilei Hong, Yingying Shen, Qi Liu, Jingjie Dong, Jingjing Xiang, Wenbin Liu, Yiping Shen, Liqiang Wu, Yuhong Zhou, Baodong Ye, Dijiong Wu

Meeting Abstract Hematology

Comparison of ATG-Based Immunosuppressive Treatment and Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Transfusion-Dependent Non-Severe Aplastic Anemia: A Single Center, Retrospective Analysis

Yuzhu Li, Yingying Shen, Wenbin Liu, Qi Liu, Ying Chen, Shan Liu, Yun Zhang, Shu Deng, Haifeng Zhuang, Zhiping Hu, Qinghong Yu, Shengyun Lin, Yuhong Zhou, Jianping Shen, Baodong Ye, Dijiong Wu

Review Hematology

Research progress on the hematopoietic microenvironment in aplastic anemia

Hangchao Li, Chenjie Zhou, Yingying Shen, Min Xu, Dijiong Wu, Baodong Ye

Summary: In recent years, the research on the hematopoietic microenvironment of AA has made some progress, providing new ideas for the clinical treatment of AA. Although the focus has been on immune abnormalities, there has been less research on the hematopoietic microenvironment of AA.

EUROPEAN JOURNAL OF HAEMATOLOGY (2023)

Article Hematology

Eltrombopag plus cyclosporine in refractory immune thrombocytopenia: a single-center study

Yilei Hong, Yingying Shen, Qi Liu, Jingjie Dong, Jingjing Xiang, Yiping Shen, Liqiang Wu, Yuhong Zhou, Baodong Ye, Dijiong Wu

Summary: The study aimed to investigate the efficacy and safety of combining low-dose cyclosporine with eltrombopag in the management of patients with refractory ITP. The results showed that 76.2% of the patients responded to the combination therapy, with no significant drug-related adverse events.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Article Medicine, General & Internal

Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre

Yingying Shen, Yuzhu Li, Qi Liu, Wenbin Liu, Qinghong Yu, Huijin Hu, Shan Liu, Jingjie Dong, Min Xu, Yaonan Hong, Ying Chen, Shu Deng, Haifeng Zhuang, Zhiping Hu, Shenyun Lin, Yiping Shen, Jianping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Summary: This study compares the efficacy and long-term outcomes of anti-thymocyte globulin (ATG)-based immunosuppressive therapy (IST) and allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with transfusion-dependent non-severe aplastic anemia (TD-NSAA). The results show that frontline IST has a higher overall response rate and event-free survival compared to non-frontline treatment, particularly in patients with a shorter disease duration. However, for patients with a longer disease duration, allo-HSCT offers better treatment outcomes than IST.

ANNALS OF MEDICINE (2023)

Review Cell Biology

Prolonged haematologic toxicity in CAR-T-cell therapy: A review

Qi Liu, Tonglin Hu, Hangchao Li, Yingying Shen, Dijiong Wu, Baodong Ye

Summary: Chimeric antigen receptor-T-cell (CAR-T-cell) therapy is a promising immunotherapy for relapsed/refractory haematologic malignancies, but prolonged haematologic toxicity (PHT) is a common yet underestimated side effect. The incidence, risk factors, and management of PHT vary across studies due to heterogeneity in populations, CAR-T cells used, diseases treated, and definitions of PHT. This review aims to provide narrative and evidence-based insights into PHT following CAR-T-cell therapy to enhance systematic understanding and treatment strategies.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2023)

Article Medicine, Research & Experimental

Acute rhabdomyolysis in hepatitis-associated aplastic anemia patient undergoing allogeneic hematopoietic stem-cell transplantation: case report and literature review

Yuzhu Li, Yilei Hong, Yingying Shen, Qi Liu, Ying Chen, Keding Shao, Yiping Shen, Baodong Ye, Dijiong Wu

Summary: This article presents a case of acute rhabdomyolysis developing during HLA-haploidentical HSCT in a patient with hepatitis-associated aplastic anemia. Despite timely diagnosis and treatment, the patient ultimately died of multi-organ failure. Whole-exome sequencing revealed a genetic mutation. The authors suggest genetic analysis should be performed during HSCT to better understand the pathological changes of this complication.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2022)

暂无数据